Bräunlich H, Rössler S, Gerhardt C
Institute of Pharmacology and Toxicology, Friedrich Schiller University, Jena, FRG.
Dev Pharmacol Ther. 1993;20(1-2):86-92. doi: 10.1159/000457544.
After simultaneous administration of dexamethasone together with 6-hydroxydopamine or adrenergic neuronal blocking agents (alpha-methyldopa, reserpine, guanethidine) the dexamethasone-stimulated increase in renal excretion of p-aminohippurate (PAH) is distinctly diminished. The same is true for dopamine. This depressive effect could be proved by measurement of transport rates of PAH in renal cortical slices in vitro. The increase in kidney weight and in the protein content of kidney tissue in dexamethasone-treated rats is lower in rats simultaneously treated with adrenergic neuronal blocking agents of 6-hydroxydopamine. Adrenoceptor agonists and antagonists (pholedrine, orciprenaline, phentolamine, propranolol) are without influence on the dexamethasone-stimulated increase in PAH transport.
在同时给予地塞米松与6-羟基多巴胺或肾上腺素能神经阻滞剂(α-甲基多巴、利血平、胍乙啶)后,地塞米松刺激的对氨基马尿酸(PAH)肾排泄增加明显减弱。多巴胺的情况也是如此。这种抑制作用可通过体外测量肾皮质切片中PAH的转运速率来证实。在用肾上腺素能神经阻滞剂或6-羟基多巴胺同时处理的大鼠中,地塞米松处理大鼠的肾脏重量增加和肾组织蛋白含量增加较低。肾上腺素能受体激动剂和拮抗剂(苯丙胺、奥西那林、酚妥拉明、普萘洛尔)对地塞米松刺激的PAH转运增加没有影响。